Donald E. Mager

Dr. Mager is Professor and Vice Chair of Pharmaceutical Sciences at the University at Buffalo, SUNY. He is also President and CEO of Enhanced Pharmacodynamics, LLC. He currently serves on the Pharmaceutical Sciences and Clinical Pharmacology Advisory Committee to the FDA and serves as an Associate or Consulting Editor at CPT:Pharmacometrics & Systems Pharmacology and Pharmacology, Research & Perspectives. He is a Fellow and former President of the International Society of Pharmacometrics and is a Fellow, member of the Board of Regents, and Treasurer of the American College of Clinical Pharmacology. Dr. Mager received the ASCPT Malle Jurima–Romet Mid-Career Leadership Award and is also a Fellow of AAPS and AAAS. In addition, he serves on the Scientific Advisory Board to Simcyp. His research focuses on identifying molecular and physiological factors that control the pharmacological properties of drugs by combining experimental data with pharmacometrics and systems pharmacology modeling, with a focus on anti-cancer and immunomodulatory agents. He served as a Co-Editor of the book Systems Pharmacology and Pharmacodynamics and has contributed to 130+ peer-reviewed publications.